Tag Archives: Stuart Titus

SeeThruEquity RSHO Raúl Elizalde

SeeThruEquity Initiates Coverage On Medical Marijuana, Inc. Investment Company AXIM Biotech (OTC: AXIM) With A Target Price Of $17.00

SeeThruEquity Initiates Coverage On Medical Marijuana, Inc. Investment Company AXIM Biotech (OTC: AXIM) With A Target Price Of $17.00

SAN DIEGO, Calif., May 17, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM) received coverage initiation from SeeThruEquity, a leading independent equity research firm focused on smallcap and microcap public companies, with a price target of $17.00.

Americans for Safe Access Opioid Veterans Senate Committee

Cannabis Patients, Advocates, and Industry Leaders Converge at National Medical Cannabis Unity Conference in D.C.

WASHINGTON, March 28, 2017 /Weed Wire/ — Starting on Friday, April 7th and running until Tuesday, April 11th, medical cannabis industry business leaders, medical and legal professionals, advocates, and patients will gather at the Unity 2017 conference in Washington, D.C. to discuss common-sense policies and approaches to safe medical cannabis access and use. With the uncertainty of policies under a new U.S. administration, 2017 will be one of the most important years for medical cannabis policy ever.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Term Sheet Agreement With U.S. API Company To Develop Bioequivalent Product To Marinol

SAN DIEGO, Calif., March 28, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB: AXIM), has entered into a Term Sheet Agreement with a U.S.-based controlled-substances API (Active Pharmaceutical Ingredient) production company to develop a dronabinol-based functional, controlled-release chewing gum product based on AXIM IP and technology.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Investment Axim Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome (IBS) with CanChew Plus Cannabidiol (CBD) Chewing Gum

NEW YORK, March 7, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and commenced its Phase II clinical trial for the treatment of irritable bowel syndrome (IBS) with the company’s CanChew Plus® CBD gum.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Receives Brazilian Government Approval for Treatment of Autism Patient Using, Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

SAN DIEGO, Calif., March 3, 2017/Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States subsidiary, HempMeds® Brasil, today announced that the Brazilian government approved a prescription for the Company’s cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country with Autism Spectrum Disorder (ASD).

SeeThruEquity RSHO Raúl Elizalde

Multiple Sclerosis Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™

SAN DIEGO, Calif., Feb. 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat patients in the country suffering from Multiple Sclerosis.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana Inc. Subsidiary, HempMeds, Announces New Affiliate Program Showcasing Customer Loyalty

SAN DIEGO, Calif., Feb. 13, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds® is announcing a new affiliate program showcasing customer loyalty by allowing them to earn a commission by referring customers to the company.

SeeThruEquity RSHO Raúl Elizalde

Alzheimer’s Patient Receives Brazilian Government Permission to be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

SAN DIEGO, Calif., Feb., 7, 2017/Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country suffering from Alzheimer’s disease.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Subsidiary HempMeds Mexico® Receives COFEPRIS Permission for Flagship Product RSHO-X™ Usage for Cancer Patient

SAN DIEGO, Jan. 24, 2017/Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds Mexico® has received permission from Mexico’s health authority COFEPRIS to import their flagship product Real Scientific Hemp Oil-X™ (RSHO-X™) to treat a patient for their pain associated with cancer treatments and for their general well-being.

MJNA and AXIM

Medical Marijuana, Inc. Subsidiary, HempMeds(R) Brasil Announces Groundbreaking Distribution Partnership with Paragon HealthCare BR

Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, has announced a groundbreaking partnership between their subsidiary, HempMeds® Brasil and Paragon HealthCare BR, one of the leading global wholesale distributors of pharmaceutical products.

SeeThruEquity RSHO Raúl Elizalde

Forbes Features Medical Marijuana, Inc. in Article Citing Company’s Sales Data After Starting CBD Market ‘That Could Grow 700% by 2020’

SAN DIEGO, Dec. 14, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company, its products and investments were featured in a Forbes article focused on the current cannabidiol (CBD) market size and anticipated massive growth.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc.’s Investment Axim(R) Biotech Files IP Application on Proprietary Method to Extract High-Purity THC

SAN DIEGO, Nov. 29, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC PINK: AXIM) has filed an IP application with the World Intellectual Property Organization.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Subsidiary HempMeds(R) Mexico Begins Distribution of Flagship Product Real Scientific Hemp Oil(TM) to Colombian Market

SAN DIEGO, Calif., Nov. 28, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its subsidiary HempMeds® Mexico, the first and only company with approval from COFEPRIS to legally import a cannabis product into Mexico, has begun distributing Real Scientific Hemp Oil™ (RSHO™) to Colombia.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. and Subsidiary HempMeds Partner With CannaNative(TM) to Produce First-Ever Cannabis Product Line for Native American Marketplace

SAN DIEGO, Calif., Aug. 15, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) and its subsidiary HempMeds® announced today a partnership with CannaNative™, LLC (“CannaNative™”) to produce the first-ever cannabis product line for the Native American marketplace.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc.’s Subsidiary HempMeds(R) Mexico to Sponsor and Exhibit at Expoweed Conference in Mexico City

SAN DIEGO, Calif., Aug. 12, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its subsidiary HempMeds® Mexico is sponsoring and exhibiting at the Aug. 12-14 ExpoWeed Conference, the first-ever cannabis conference to be held in Mexico.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Hires New Director of Human Resources to Support Company’s Rapid Growth, International Expansion

SAN DIEGO, Aug. 1, 2016/Weed Wire/ — Medical Marijuana, Inc.’s (OTC PINK: MJNA) management team today announced that Melissa Temple-Agosta has been hired as Director of Human Resources, reporting directly to Senior Vice President of Operations Blake Schroeder.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Now Hiring for Sales and Marketing Positions for Booming Cannabis Industry

SAN DIEGO, July 28, 2016 /Weed Wire/ — Medical Marijuana, Inc.’s (OTC PINK: MJNA) management team announced today that it’s currently hiring for open sales and marketing positions, as the Company continues its rapid expansion.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Portfolio Company Kannalife Featured in Sports Illustrated Article About Research That Could Be “Future New Wave of Medicine”

SAN DIEGO, Calif., July 15, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its portfolio company Kannalife Sciences, Inc. was the focus of a Sports Illustrated online article about how the breakthrough cannabinoid research the Company is conducting could be the “future new wave of medicine” for traumatic brain injuries.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Receives New Permit to Export Into Paraguay, Plans New Latin America Expansion

SAN DIEGO, Calif., July 5, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that the Paraguay government has issued a new import permit for the Company’s flagship product Real Scientific Hemp Oil™ (RSHO™) for a new patient in the country.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Receives 22 More Permits to Export Into Estimated $10-12 Billion Market in Mexico

SAN DIEGO, June 28, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that Mexico’s government has approved 22 additional import permits for Real Scientific Hemp Oil-X™ (RSHO-X™), expanding the Company’s foothold into a market projected to eventually reach $10-12 billion annually.

MJNA and AXIM

Medical Marijuana, Inc. Announces Investment in AXIM Biotechnologies

SAN DIEGO, June 30, 2015 /Weed Wire/ — Medical Marijuana, Inc. (OTC Pink:MJNA) would like to inform the public and shareholders that it holds 14,943,650 shares of common stock and 500,000 shares of preferred stock in AXIM Biotechnologies(AXIM), a cutting-edge biotechnology innovator.


Top